Arizona Tribune - Boulevard

NYSE - LSE

BCC	0.74%	90.598	$
NGG	0.54%	63.08	$
CMSC	-1.28%	21.93	$
BTI	0%	39.55	$
BCE	-0.07%	20.855	$
RIO	0.89%	52.79	$
GSK	-3.99%	32.82	$
BP	-1.6%	25.7	$
AZN	-4.39%	62.173	$
RBGPF	-12.83%	60.27	$
RYCEF	1.3%	8.49	$
SCS	1.91%	9.93	$
CMSD	-0.45%	22.28	$
JRI	-0.44%	11.42	$
VOD	-0.06%	8.185	$
RELX	1.13%	45.828	$

Featured

Over 120 dead in Dominican Republic nightclub disaster

Rescue workers raced Wednesday to find any remaining survivors under the rubble of a Dominican Republic nightclub, a day after the roof collapsed, killing at least 124 people in the country's worst disaster in two decades.

'Curve ball': Irish whiskey producers fret over US tariffs

For Tony Healy, an Irish whiskey producer in Dundalk, near the UK border with Northern Ireland, US tariffs of 20 percent on EU alcoholic drinks were a huge and unexpected "curve ball".

Last news

Family fights for death-row retrial under Japan's 'snail-paced' system

Since his teenage years, Koji Hayashi has dreaded one thing: his stubborn, once-vivacious mother being hanged for murder after failing to win her long campaign for a retrial.

South Korea's life game 'InZOI' challenges 'The Sims'

South Korean game publisher Krafton released early access to its life simulation game "InZOI" Friday, hoping its powerful lifelike graphics will unseat the decades-long dominance of "The Sims" hit franchise.

Man charged with destroying Teslas in Las Vegas, amid anti-Musk wave

A man who allegedly set fire to five Teslas and sprayed them with bullets from a semi-automatic rifle appeared in a US court Thursday to face federal arson charges, the Department of Justice said.

Genflow Biosciences PLC Announces Director Dealings

THE INFORMATION CONTAINED WITHIN THIS ANNOUNCEMENT IS DEEMED BY THE COMPANY TO CONSTITUTE INSIDE INFORMATION AS STIPULATED UNDER THE MARKET ABUSE REGULATION (EU) NO. 596/2014 AS IT FORMS PART OF UK DOMESTIC LAW PURSUANT TO THE EUROPEAN UNION (WITHDRAWAL) ACT 2018, AS AMENDED. UPON THE PUBLICATION OF THIS ANNOUNCEMENT VIA A REGULATORY INFORMATION SERVICE, THIS INFORMATION IS CONSIDERED TO BE IN THE PUBLIC DOMAIN.

Genflow Biosciences PLC Announces Holding in Company

LONDON, UNITED KINGDOM / ACCESS Newswire / March 28, 2025 / 1. Issuer Details

International Medication Systems, Ltd. Receives FDA's Drug Shortage Assistance Award

Recognized for contributions to address shortage of epinephrine injection, 0.1 mg/mL syringes

Two of LQR House Stockholders, Including Its CEO, Enter Lock-up Agreement Covering at Least 209,543 Shares

MIAMI BEACH, FL / ACCESS Newswire / March 28, 2025 / LQR House Inc. (the "Company" or "LQR House") (NASDAQ:YHC), a niche e-commerce platform specializing in the spirits and beverage industry, today announced that two of its stockholders, including its Chief Executive Officer, signed 12-month lock-up agreements, covering 209,543 shares of the Company's common stock that they now own and any future shares of common stock they may acquire during 12 months lock-up period. Currently this represents approximately 0.6% of LQR House's outstanding shares. Both agreements restrict the sale of shares and other securities that can be acquired by these stockholders for 12 months, i.e. until January and March 2026 respectively.

UniDoc Completes Purchase of AGNES Connect(R) Software from AMD Telemedicine

VANCOUVER, BC / ACCESS Newswire / March 28, 2025 / UniDoc Health Corp. (CSE:UDOC)(FRA:L7T)(OTCQB:UDOCF) ("UniDoc" or the "Company"), announces that, further to its news release dated March 19, 2025, it has closed the acquisition of the AGNES Connect software from AMD Telemedicine ("AMD").

83.33% of Veterinary Oncologists Highlight Importance of Jaguar Health's FDA Conditionally Approved Canalevia-CA1 as a Non-Antibiotic Treatment for Chemotherapy-Induced Diarrhea (CID) in Dog's in New Survey

Canalevia®-CA1 (crofelemer delayed-release tablets) is the first and only treatment for CID in dogs to receive any type of approval from the FDAIn dogs undergoing chemotherapy, as is the case with people undergoing cancer treatment, diarrhea is a highly neglected and unmet medical need

Quantum Biopharma's 2024 Financial Statements Show Strong Improvements in Cash, Working Capital, Operating Efficiency and the Removal of Material Uncertainty Related to Going Concern

Completion of unbuzzdTM Clinical Trial and Multiple Sclerosis Drug Lucid-21-302 Phase 1 Trial Advance Company's Pipeline of Products and Assets

Juan Ardila: Bringing Government to the People with Mobile Office Hours

NEW YORK CITY, NY / ACCESS Newswire / March 28, 2025 / In an era where many elected officials are criticized for being out of touch with their constituents, Juan Ardila set out to change that. As an Assemblyman for Western Queens, he prioritized accessibility, launching mobile office hours to meet with residents across the district. Instead of requiring people to travel to a central office, Ardila and his team brought government services directly to the community.

Judge hears Associated Press suit over White House denial of access

Lawyers for the Associated Press (AP) urged a federal judge on Thursday to restore the news agency's reporters access to the White House press pool that covers US President Donald Trump's events.

Games publisher Ubisoft announces restructuring, billion-euro investment

In a bid to escape financial woes, French games giant Ubisoft said Thursday it was creating a new subsidiary around its most popular franchises such as "Assassin's Creed" in partnership with China's Tencent.

Salman Rushdie to publish first fiction book since stabbing

British-American novelist Salman Rushdie will publish his first major work of fiction since the brutal stabbing that blinded him in one eye, his publisher said on Thursday.

Six Russians dead in sinking of Egypt tourist submarine

Six Russian tourists, including two minors, died on Thursday when a submarine carrying dozens of passengers sank off a major resort town on Egypt's Red Sea coast.

Water cannon break up Indonesia military law protests

Indonesian police fired water cannons Thursday to disperse hundreds of protesters in the capital Jakarta angry at a newly passed military law, AFP reporters said.

Six dead in sinking of Egypt tourist submarine

Six people died on Thursday, two of them minors, when a tourist submarine carrying dozens of Russian visitors sank off Egypt's Red Sea coast near a major resort town.

Six dead in sinking of Egyptian tourist sub carrying Russians

Six people died on Thursday when a tourist submarine sank off Egypt's Red Sea coast, state media reported, with Russia's consulate saying 45 Russian citizens were aboard.

Israel parliament passes law enabling political control over judicial appointments

Israel's parliament on Thursday passed a law expanding elected officials' power to appoint judges, defying a years-long movement against Prime Minister Benjamin Netanyahu's contentious judicial reforms that saw massive street protests.

South Korea wildfires 'largest on record': disaster chief

Wildfires in South Korea are now "the largest on record" having burned more forest than any previous blaze, the country's disaster chief said Thursday, as the death toll rose to 26.

DEA Delays Threaten U.S. Leadership in Global Cannabis Pharma Market Despite FDA Advances

Duane Boise, CEO of MMJ International Holdings, expressed frustration over the contrasting approaches of federal agencies, stating, "While the FDA is facilitating medical innovation, the DEA's hindrance not only blocks scientific progress but also contradicts directives aimed at revitalizing domestic manufacturing." This situation starkly contrasts with the "Buy American" initiative endorsed by President Trump in 2020, which was intended to strengthen U.S. drug production capabilities and reduce dependence on foreign manufacturers.

Bausch Health to Announce First Quarter Results on April 30

LAVAL, QC / ACCESS Newswire / March 27, 2025 / Bausch Health Companies Inc. (NYSE:BHC)(TSX:BHC) will release first quarter financial results after market close on Wednesday, April 30, 2025. Bausch Health will host a conference call and live webcast at 5:00 p.m. U.S. EDT to discuss the results and provide a business update. All materials will be made available on the Investor Relations section of the Bausch Health website prior to the start of the call.

NHI Announces Appointment of Robert W. Chapin, Jr. to the Board of Directors

MURFREESBORO, TN / ACCESS Newswire / March 27, 2025 / National Health Investors, Inc. (NYSE:NHI) (the "Company" or "NHI") announced today that Robert W. Chapin, Jr. is joining the NHI Board of Directors (the "Board") effective immediately.

CBD Life Sciences Inc. (CBDL) Launches Passion Fuel Cordyceps Complex - A Powerful Sexual Enhancement Supplement

The global sexual wellness market is projected to surpass $125 billion by 2026, with the supplement industry experiencing rapid growth as consumers seek natural solutions for enhanced performance and vitality.

Jaguar Health Meeting with FDA Regarding Results of Phase 3 OnTarget Study

The statistically significant responder analysis results for Mytesi® (crofelemer) in the OnTarget study's prespecified subgroup of patients with breast cancer were the subject of a December 2024 poster presentation at the San Antonio Breast Cancer SymposiumLate-breaker abstract recently submitted to the Multinational Association of Supportive Care in Cancer (MASCC) shows additional significant results for breast cancer subgroupThe American Cancer Society expects 316,950 new cases of breast cancer diagnosed in women in the US in 2025, and it's estimated that there were 4 million US women with a history of invasive breast cancer in 2022

CV Sciences, Inc. Reports Fiscal Year-End 2024 Financial Results

SAN DIEGO, CA / ACCESS Newswire / March 27, 2025 / CV Sciences, Inc. (OTCQB:CVSI) (the "Company", "CV Sciences", "our", "us" or "we"), a preeminent consumer wellness company specializing in hemp extracts and other proven science-backed, natural ingredients and products, today announced its financial results for the year and quarter ended December 31, 2024.

Workshops and Lectures Announced for Specialty Coffee Expo 2025: Focused Hands-On Learning Across the Coffee Value Chain

Brand-New Learning Opportunities are Tailored Around Cupping and Retail Businesses

Dolphin Partner Loti AI Expands Digital Identity Protection To Everyone

Advanced AI-powered Reputation Management and Content Takedown Services-Once Reserved for Celebrities-Now Available to All

Munich Was a Warning - The West Made It a Blueprint

NAPERVILLE, IL / ACCESS Newswire / March 27, 2025 / Gaza is burning. It has been for decades, yet it is treated as though it erupted from nowhere. Every escalation is framed as a sudden explosion of violence rather than the result of long-standing political failures. The international community reacts with shock-calling for restraint, condemning attacks, and expressing concern over civilian casualties. Then the moment passes. The cycle resets. Nothing changes.

Dolphin Reports 20% Year-Over-Year Revenue Growth to $51.7 Million and Full-Year Positive Adjusted Operating Income for Fiscal Year 2024

MIAMI, FL / ACCESS Newswire / March 27, 2025 / Dolphin (NASDAQ:DLPN), a leading entertainment marketing and content production company, today announced its financial results for the fourth quarter and full year ended December 31, 2024.

Interactive Strength Inc. (Nasdaq:TRNR)'s FORME Named an Exclusive Wellness Partner for Virgin Atlantic's New Clubhouse at LAX

Partnership Raises FORME's Visibility with Affluent Customers, Highlights Brand's Seamless Integration into Premium Hospitality and Travel EnvironmentsInstallation adds to Hospitality Customers such as Four Seasons, Bulgari and Mandalay Bay Resort

Dermata Therapeutics Announces Exercise of Warrants for $6.2 Million in Gross Proceeds Priced At-the-Market Under Nasdaq Rules

SAN DIEGO, CA / ACCESS Newswire / March 27, 2025 / Dermata Therapeutics, Inc. (NASDAQ:DRMA)(NASDAQ:DRMAW) ("Dermata," or the "Company"), a late-stage biotechnology company focused on the treatment of medical skin diseases and aesthetic applications, today announced the entry into a definitive agreement for the immediate exercise of certain outstanding warrants to purchase an aggregate of 4,834,470 shares of the Company's common stock, having exercise prices of $1.58 and $4.91 per share, issued by Dermata in September 2024 (with respect to 3,825,138 warrants) and May 2024 (with respect to 1,009,332 warrants), at a reduced exercise price of $1.284 per share. The shares of common stock issuable upon exercise of the warrants are registered pursuant to effective registration statements on Form S-3 (File Nos. 333-282223 and 333-280682). The closing of the offering is expected to occur on or about March 28, 2025, subject to satisfaction of customary closing conditions.

Arizona Tribune - Boulevard (English)